Identification of a Novel GOLGB1-RET Fusion in Papillary Thyroid Cancer With a Durable Response to Selpercatinib
JCO Precision Oncology · 2026-07 · 10 (7)
DOI: 10.1200/po-26-00237 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Precision Oncology, 2026-07. Verfasst von Shogen Boku und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Oncology, Kansai Medical University Hospital, Hirakata City, Osaka, Japan. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Clinical Oncology, Kansai Medical University Hospital, Hirakata City, Osaka, Japan.
- Department of the Promotion of Drug and Diagnostic Development, National Cancer Center Hospital East, Kashiwa City, Chiba, Japan.
- Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa City, Chiba, Japan.
- Department of Clinical Oncology, Aichi Cancer Center Hospital, Chikusa-ku, Nagoya City, Aichi, Japan.
- Department of Medical Oncology, Kochi Medical School, Kohasu, Oko-cho, Nankoku City, Kochi, Japan.
- Department of Medical Oncology, Kobe City Medical Center General Hospital, Chuo-ku, Kobe City, Hyogo, Japan.
ORCID-Profile: Shogen Boku, Takao Fujisawa, Shigenori Kadowaki, Hironaga Satake, Hisateru Yasui, Tomoyuki Otsuka, Riu Yamashita, Taro Shibuki, Yoshiaki Nakamura, Hideaki Bando, Takayuki Yoshino, Milan Radovich, Susumu Okano
Zitieren
APA
Boku, S., Fujisawa, T., Kadowaki, S., Satake, H., Yasui, H., Ohtsubo, K., Shimizu, Y., Otsuka, T., Kuze, B., Yamashita, R., Shibuki, T., Nakamura, Y., Bando, H., Yoshino, T., Radovich, M., & Okano, S. (2026). Identification of a Novel GOLGB1-RET Fusion in Papillary Thyroid Cancer With a Durable Response to Selpercatinib. JCO Precision Oncology, 10(7). https://doi.org/10.1200/po-26-00237
Vancouver
Boku S, Fujisawa T, Kadowaki S, Satake H, Yasui H, Ohtsubo K, et al. Identification of a Novel GOLGB1-RET Fusion in Papillary Thyroid Cancer With a Durable Response to Selpercatinib. JCO Precision Oncology. 2026;10(7). doi:10.1200/po-26-00237
BibTeX
@article{Boku2026,
author = {Boku, Shogen and Fujisawa, Takao and Kadowaki, Shigenori and Satake, Hironaga and Yasui, Hisateru and Ohtsubo, Koushiro and Shimizu, Yasushi and Otsuka, Tomoyuki and Kuze, Bunya and Yamashita, Riu and Shibuki, Taro and Nakamura, Yoshiaki and Bando, Hideaki and Yoshino, Takayuki and Radovich, Milan and Okano, Susumu},
title = {Identification of a Novel GOLGB1-RET Fusion in Papillary Thyroid Cancer With a Durable Response to Selpercatinib},
journal = {JCO Precision Oncology},
year = {2026},
volume = {10},
number = {7},
doi = {10.1200/po-26-00237}
}
EUVIMED